Search results
I tried getting my prescriptions from Amazon Pharmacy's new RxPass. It took forever, so I'll stick...
Business Insider via Yahoo Finance· 1 year agoAmazon Pharmacy's new RxPass is a subscription to get generic prescription medications for $5 a...
Europe's generic drugmakers say they may cut output due to energy bills
Reuters via Yahoo News· 2 years agoEurope's drugmakers have warned they may stop making some cheap generic medicines because of surging...
The generic drugs in you cabinet may have never been tested. That can't continue| Opinion
The Columbus Dispatch via Yahoo News· 2 years agoRosemary Gibson is author of "China Rx" and chairwoman of the Healthcare Committee for the Coalition...
Amazon just introduced RxPass, a Prime benefit that provides generic medicines for $5 a month
USA TODAY via Yahoo Finance· 1 year agoAs of Tuesday, Amazon Prime members will now have access to RxPass, which costs $5 per month and...
Which Is the Better Dividend Stock: Viatris or Apple?
Motley Fool· 1 year agoViatris (NASDAQ: VTRS) and Apple (NASDAQ: AAPL) are two dividend-paying stocks that don't have much...
European Drug Makers Say Higher Energy Costs Eating Margins: Report
Benzinga via Yahoo Finance· 2 years agoEurope's drug makers have warned about stopping manufacturing some cheap generic medicines amid...
These 2 No-Brainer Growth Stocks Are Breaking New Ground
Motley Fool via Yahoo Finance· 1 week agoDrugmakers outside the biosimilar or generic-medicine market must constantly innovate to be...
7 key questions about worsening drug shortages, answered
LA Times via Yahoo News· 1 year agoAdderall, Ozempic, albuterol, antibiotics and lifesaving cancer meds are in short supply. Here are...
Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy?
Motley Fool· 12 months agoOn May 18, Teva Pharmaceuticals (NYSE: TEVA) announced that it was planning to execute a strategic...
Zacks Industry Outlook Highlights Dr. Reddy's, Amphastar Pharmaceuticals and Sol-Gel Technologies
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – December 8, 2022 – Today, Zacks Equity Research discusses Dr....